- Country: USA
- Summary: GenePrint(R) 24 System, 400rxn Kits
- UST Ref No: 114570935
- Deadline: 20 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 25-002231
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
GenePrint(R) 24 System, 400rxn Kits
Product Service Code: 6550 NAICS Code: 325413 Place of Performance: National Institutes of Health Clinical Center 10 Center Drive
Bethesda, MD 20892
POTS: 25-002231
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health, Office of Purchasing and Contracts, on behalf of the Department of Laboratory Medicine, Hematology Service, intends to issue a firm-fixed price Purchase Order to Promega Corporation, located at 2800 Woods Hollow Rd, Fitchburg, Wisconsin 53711-5300. The order will cover a six (6) month base year, with two (2) additional twelve (12) month option years, for the GenePrint® 24 System, 400rxn Kits (Product Code: B1874). Period of Performance: 03/01/2025-09/30/2027.
The Department of Laboratory Medicine, Hematology Service, conducts engraftment monitoring Chimerism Testing in the clinical laboratory for patients who have undergone allogeneic transplants. The GenePrint® 24 System kits are utilized to amplify Short Tandem Repeats (STR) for monitoring the engraftment chimerism of donor pluripotent cells in bone marrow and stem cell transplant patients. The GenePrint® 24 System, 400rxn Kits are the only kits that have been fully validated for this use and can generate the required number of loci for the protocol. Promega Corporation is the sole manufacturer and supplier of these proprietary kits. Without the GenePrint® 24 System, 400rxn kits, patient treatment and care would be negatively impacted.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation 13.501 Special documentation requirements for sole source acquisitions exceeding the Simplified Acquisition Threshold.
Interested Parties:
Interested parties capable of providing the same or similar products or services described in this notice may s... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINGenePrint(R) 24 System, 400rxn Kits - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for GenePrint(R) 24 System, 400rxn Kits. This tender is published on USARFP under UST Ref No: 114570935 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-20.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
